DiaMedica Therapeutics Inc. (DMAC) Receivables (2018 - 2019)
DiaMedica Therapeutics (DMAC) has 2 years of Receivables data on record, last reported at $689000.0 in Q3 2019.
- For Q3 2019, Receivables changed N/A year-over-year to $689000.0; the TTM value through Sep 2019 reached $689000.0, changed N/A, while the annual FY2018 figure was $1.4 million, N/A changed from the prior year.
- Receivables reached $689000.0 in Q3 2019 per DMAC's latest filing, down from $2.1 million in the prior quarter.
- Across five years, Receivables topped out at $2.1 million in Q2 2019 and bottomed at $689000.0 in Q3 2019.